Foot & Ankle Center Of Illinois | Springfield, IL
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Full description
This study will evaluate the safety and efficacy of bacteriophage therapy in patients with diabetic foot osteomyelitis (DFO). Enrolled patients will have osteomyelitis infections due to Staph aureus. This study will include eligible patients who have undergone or are planning to undergo surgical debridement of DFO.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
126 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Staci Steele
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal